It’s been a choppy year for infrastructure investors, but much of the worry is overdone, says Max King.
Articles written by Max King
Last week’s Budget pleased nobody. But in a few years’ time we may look back on it as the point when the clouds started to lift, says Max King.
After a disappointing few years, the future looks bright for the Baillie Gifford UK Growth Fund.
The Worldwide Healthcare Trust provides investors with access to exciting opportunities, says Max King.
The Henderson Euro Trust finds value in European stocks, says Max King.
Pershing Square, US activist Bill Ackman’s fund, struggled when it floated in 2014. But it is now reviving and looks cheap.
US tech stocks continue to lead the global market upswing. The boom shows no sign of ending.
High-profile venture-capital successes tempt ordinary investors, but be careful, says Max King.
Department stores, including House of Fraser, Debenhams and others, are in trouble. But history shows this retail format has the capacity to reinvent itself and bounce back, says Max King.
BioPharma Credit, a life-sciences investment trust, offers a tempting yield. But the dangers may be high when the credit cycle turns.